Use of gadolinium contrast agents in paediatric [pediatric] population: Donald Rumsfeld meets Hippocrates! (Feb 2019).

Pediatric

Feb 7

Written By Bridget Belo

Journal: British Journal of Radiology, Volume 92, Issue 1094, 1 February 2019

Download Article

Article link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6404820/

Author and Affiliations: Ruchir Shah, Felice D’Arco, Bruno Soares, Jessica Cooper, Joe Brierley

1 UCL Medical School, UCL, London, UK 2Great Ormond Street Hospital, London, UK 3John Hopkins Hospital, Baltimore, MD, USA Address correspondence to: Mr Ruchir Shah E-mail: ruchir.shah.13@ucl.ac.uk

Bridget Belo

A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine: A Controlled Prospective Comparison Study (2019).

Gadolinium as an Emerging Microcontaminant in Water Resources: Threats and Opportunities (2019).

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com

Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.